The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Nitroglycerin for Angina Market Research Report 2024
Synopsis
Nitroglycerin is a nitrate vasodilator indicated for relief of an attack or prophylaxis of angina pectoris due to coronary artery disease.
The global Nitroglycerin for Angina market was valued at US$ 324 million in 2023 and is anticipated to reach US$ 505.1 million by 2030, witnessing a CAGR of 6.2% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Nitroglycerin for Angina, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nitroglycerin for Angina.
Report Scope
The Nitroglycerin for Angina market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Nitroglycerin for Angina market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Nitroglycerin for Angina manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer
Espero Pharmaceuticals
Us Pharma
Mylan
Sandoz
Hercon Pharmaceuticals
Glenmark
Sigmapharm Laboratories
Dr. Reddy's Laboratories
Segment by Type
Tablet
Powder
Transdermal
Segment by Application
Relief
Prophylaxis
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Nitroglycerin for Angina manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Nitroglycerin for Angina in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Nitroglycerin is a nitrate vasodilator indicated for relief of an attack or prophylaxis of angina pectoris due to coronary artery disease.
The global Nitroglycerin for Angina market was valued at US$ 324 million in 2023 and is anticipated to reach US$ 505.1 million by 2030, witnessing a CAGR of 6.2% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Nitroglycerin for Angina, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nitroglycerin for Angina.
Report Scope
The Nitroglycerin for Angina market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Nitroglycerin for Angina market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Nitroglycerin for Angina manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer
Espero Pharmaceuticals
Us Pharma
Mylan
Sandoz
Hercon Pharmaceuticals
Glenmark
Sigmapharm Laboratories
Dr. Reddy's Laboratories
Segment by Type
Tablet
Powder
Transdermal
Segment by Application
Relief
Prophylaxis
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Nitroglycerin for Angina manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Nitroglycerin for Angina in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Nitroglycerin for Angina Market Overview
1.1 Product Overview and Scope of Nitroglycerin for Angina
1.2 Nitroglycerin for Angina Segment by Type
1.2.1 Global Nitroglycerin for Angina Market Value Comparison by Type (2024-2030)
1.2.2 Tablet
1.2.3 Powder
1.2.4 Transdermal
1.3 Nitroglycerin for Angina Segment by Application
1.3.1 Global Nitroglycerin for Angina Market Value by Application: (2024-2030)
1.3.2 Relief
1.3.3 Prophylaxis
1.4 Global Nitroglycerin for Angina Market Size Estimates and Forecasts
1.4.1 Global Nitroglycerin for Angina Revenue 2019-2030
1.4.2 Global Nitroglycerin for Angina Sales 2019-2030
1.4.3 Global Nitroglycerin for Angina Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Nitroglycerin for Angina Market Competition by Manufacturers
2.1 Global Nitroglycerin for Angina Sales Market Share by Manufacturers (2019-2024)
2.2 Global Nitroglycerin for Angina Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Nitroglycerin for Angina Average Price by Manufacturers (2019-2024)
2.4 Global Nitroglycerin for Angina Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Nitroglycerin for Angina, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Nitroglycerin for Angina, Product Type & Application
2.7 Nitroglycerin for Angina Market Competitive Situation and Trends
2.7.1 Nitroglycerin for Angina Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Nitroglycerin for Angina Players Market Share by Revenue
2.7.3 Global Nitroglycerin for Angina Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Nitroglycerin for Angina Retrospective Market Scenario by Region
3.1 Global Nitroglycerin for Angina Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Nitroglycerin for Angina Global Nitroglycerin for Angina Sales by Region: 2019-2030
3.2.1 Global Nitroglycerin for Angina Sales by Region: 2019-2024
3.2.2 Global Nitroglycerin for Angina Sales by Region: 2025-2030
3.3 Global Nitroglycerin for Angina Global Nitroglycerin for Angina Revenue by Region: 2019-2030
3.3.1 Global Nitroglycerin for Angina Revenue by Region: 2019-2024
3.3.2 Global Nitroglycerin for Angina Revenue by Region: 2025-2030
3.4 North America Nitroglycerin for Angina Market Facts & Figures by Country
3.4.1 North America Nitroglycerin for Angina Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Nitroglycerin for Angina Sales by Country (2019-2030)
3.4.3 North America Nitroglycerin for Angina Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Nitroglycerin for Angina Market Facts & Figures by Country
3.5.1 Europe Nitroglycerin for Angina Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Nitroglycerin for Angina Sales by Country (2019-2030)
3.5.3 Europe Nitroglycerin for Angina Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Nitroglycerin for Angina Market Facts & Figures by Country
3.6.1 Asia Pacific Nitroglycerin for Angina Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Nitroglycerin for Angina Sales by Country (2019-2030)
3.6.3 Asia Pacific Nitroglycerin for Angina Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Nitroglycerin for Angina Market Facts & Figures by Country
3.7.1 Latin America Nitroglycerin for Angina Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Nitroglycerin for Angina Sales by Country (2019-2030)
3.7.3 Latin America Nitroglycerin for Angina Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Nitroglycerin for Angina Market Facts & Figures by Country
3.8.1 Middle East and Africa Nitroglycerin for Angina Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Nitroglycerin for Angina Sales by Country (2019-2030)
3.8.3 Middle East and Africa Nitroglycerin for Angina Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Nitroglycerin for Angina Sales by Type (2019-2030)
4.1.1 Global Nitroglycerin for Angina Sales by Type (2019-2024)
4.1.2 Global Nitroglycerin for Angina Sales by Type (2025-2030)
4.1.3 Global Nitroglycerin for Angina Sales Market Share by Type (2019-2030)
4.2 Global Nitroglycerin for Angina Revenue by Type (2019-2030)
4.2.1 Global Nitroglycerin for Angina Revenue by Type (2019-2024)
4.2.2 Global Nitroglycerin for Angina Revenue by Type (2025-2030)
4.2.3 Global Nitroglycerin for Angina Revenue Market Share by Type (2019-2030)
4.3 Global Nitroglycerin for Angina Price by Type (2019-2030)
5 Segment by Application
5.1 Global Nitroglycerin for Angina Sales by Application (2019-2030)
5.1.1 Global Nitroglycerin for Angina Sales by Application (2019-2024)
5.1.2 Global Nitroglycerin for Angina Sales by Application (2025-2030)
5.1.3 Global Nitroglycerin for Angina Sales Market Share by Application (2019-2030)
5.2 Global Nitroglycerin for Angina Revenue by Application (2019-2030)
5.2.1 Global Nitroglycerin for Angina Revenue by Application (2019-2024)
5.2.2 Global Nitroglycerin for Angina Revenue by Application (2025-2030)
5.2.3 Global Nitroglycerin for Angina Revenue Market Share by Application (2019-2030)
5.3 Global Nitroglycerin for Angina Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Corporation Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Nitroglycerin for Angina Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Pfizer Nitroglycerin for Angina Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Espero Pharmaceuticals
6.2.1 Espero Pharmaceuticals Corporation Information
6.2.2 Espero Pharmaceuticals Description and Business Overview
6.2.3 Espero Pharmaceuticals Nitroglycerin for Angina Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Espero Pharmaceuticals Nitroglycerin for Angina Product Portfolio
6.2.5 Espero Pharmaceuticals Recent Developments/Updates
6.3 Us Pharma
6.3.1 Us Pharma Corporation Information
6.3.2 Us Pharma Description and Business Overview
6.3.3 Us Pharma Nitroglycerin for Angina Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Us Pharma Nitroglycerin for Angina Product Portfolio
6.3.5 Us Pharma Recent Developments/Updates
6.4 Mylan
6.4.1 Mylan Corporation Information
6.4.2 Mylan Description and Business Overview
6.4.3 Mylan Nitroglycerin for Angina Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Mylan Nitroglycerin for Angina Product Portfolio
6.4.5 Mylan Recent Developments/Updates
6.5 Sandoz
6.5.1 Sandoz Corporation Information
6.5.2 Sandoz Description and Business Overview
6.5.3 Sandoz Nitroglycerin for Angina Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Sandoz Nitroglycerin for Angina Product Portfolio
6.5.5 Sandoz Recent Developments/Updates
6.6 Hercon Pharmaceuticals
6.6.1 Hercon Pharmaceuticals Corporation Information
6.6.2 Hercon Pharmaceuticals Description and Business Overview
6.6.3 Hercon Pharmaceuticals Nitroglycerin for Angina Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Hercon Pharmaceuticals Nitroglycerin for Angina Product Portfolio
6.6.5 Hercon Pharmaceuticals Recent Developments/Updates
6.7 Glenmark
6.6.1 Glenmark Corporation Information
6.6.2 Glenmark Description and Business Overview
6.6.3 Glenmark Nitroglycerin for Angina Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Glenmark Nitroglycerin for Angina Product Portfolio
6.7.5 Glenmark Recent Developments/Updates
6.8 Sigmapharm Laboratories
6.8.1 Sigmapharm Laboratories Corporation Information
6.8.2 Sigmapharm Laboratories Description and Business Overview
6.8.3 Sigmapharm Laboratories Nitroglycerin for Angina Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Sigmapharm Laboratories Nitroglycerin for Angina Product Portfolio
6.8.5 Sigmapharm Laboratories Recent Developments/Updates
6.9 Dr. Reddy's Laboratories
6.9.1 Dr. Reddy's Laboratories Corporation Information
6.9.2 Dr. Reddy's Laboratories Description and Business Overview
6.9.3 Dr. Reddy's Laboratories Nitroglycerin for Angina Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Dr. Reddy's Laboratories Nitroglycerin for Angina Product Portfolio
6.9.5 Dr. Reddy's Laboratories Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Nitroglycerin for Angina Industry Chain Analysis
7.2 Nitroglycerin for Angina Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Nitroglycerin for Angina Production Mode & Process
7.4 Nitroglycerin for Angina Sales and Marketing
7.4.1 Nitroglycerin for Angina Sales Channels
7.4.2 Nitroglycerin for Angina Distributors
7.5 Nitroglycerin for Angina Customers
8 Nitroglycerin for Angina Market Dynamics
8.1 Nitroglycerin for Angina Industry Trends
8.2 Nitroglycerin for Angina Market Drivers
8.3 Nitroglycerin for Angina Market Challenges
8.4 Nitroglycerin for Angina Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
